Dramatic Advances in HER2+ Breast Cancer over the Past 10 Years

In an interview with OncLive, Dr. Sara Hurvitz, from UCLA,  discusses ongoing advances that continue to revolutionize the treatment of patients with HER2+ breast cancer.
See more